Consistent with human data, we observed an inverse correlation between Creld2 and Fasn expression and a higher Creld2 to Fasn ratio in the livers obtained from control mice compared to NASH mice livers (Figure 8B). The gene discussed is CRELD2; the disease is metabolic dysfunction-associated steatohepatitis.